JPS5984161A - Solid-phase carrier for immune measurement - Google Patents

Solid-phase carrier for immune measurement

Info

Publication number
JPS5984161A
JPS5984161A JP19469782A JP19469782A JPS5984161A JP S5984161 A JPS5984161 A JP S5984161A JP 19469782 A JP19469782 A JP 19469782A JP 19469782 A JP19469782 A JP 19469782A JP S5984161 A JPS5984161 A JP S5984161A
Authority
JP
Japan
Prior art keywords
carrier
antibody
phase carrier
solid
solid phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP19469782A
Other languages
Japanese (ja)
Inventor
Kunio Ooyama
大山 邦夫
Susumu Watanabe
晋 渡辺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Jozo KK
Original Assignee
Toyo Jozo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Jozo KK filed Critical Toyo Jozo KK
Priority to JP19469782A priority Critical patent/JPS5984161A/en
Publication of JPS5984161A publication Critical patent/JPS5984161A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545Synthetic resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PURPOSE:To enable quick immune reaction under a uniform condition without the need for any laborious operation and with the use of an extremely small amt. of an immune reaction medium by using a styrene polymer incorporated therein with a sulfonic acid group in constituting a solid-phase carrier for immune measurement. CONSTITUTION:A solid-phase carrier made of polystyrene molded to a prescribed shape is subjected to a pretreatment for one hour at 5 deg.C and thereafter it is put into a cooled concd. sulfuric acid and is brought into reaction preferably for 6hr. The solid-phase carrier is removed from said acid after the reaction and is thoroughly washed with distilled water. When the carrier is further thoroughly washed repeatedly with 100mM phosphoric acid buffer soln. (8.0pH), a polystyrene solid-phase carrier 1 incorporated therein with the sulfonic acid group is obtd. The resulting carrier 1 has an extremely large amt. of immobilizing antibody per carrier and therefore a satisfactory immune measurement is made possible with an extremely small amt. of the antibody as well. Since the coupled antibody exists in an extremely stable form, the carrier withstands long-time and frequent use and has a good rate of maintaining the activity of the antibody.

Description

【発明の詳細な説明】 本発明は新規な免疫測定用固相担体に関する。[Detailed description of the invention] The present invention relates to a novel solid phase carrier for immunoassay.

従来よ)抗原抗体反応およびこれに類する反応を定員的
に行うための手段は数多く知られている。
Many means are known for carrying out antigen-antibody reactions (conventionally) and similar reactions in a large capacity.

このような方法は主として血液、栄などの体液中に微量
に存在する成分の′i?、t、定性などに応用されてい
る。微量の成分としては、生体成分としての種々のホル
モンなどの生理活性物質、生体内のアイソザイム、投与
された薬物や薬物に対する特異的抗体、微生物由来の抗
原成分や、微生物やその抗原成分に対する特異的抗体、
さらにこれらの代謝物など種々の生体内に存在する微M
゛成分があげられる。
This method is mainly used to detect components that exist in trace amounts in body fluids such as blood and blood. , t, is applied to qualitative, etc. Trace components include physiologically active substances such as various hormones as biological components, isozymes in the body, administered drugs and specific antibodies against drugs, antigen components derived from microorganisms, and specific antibodies against microorganisms and their antigen components. antibody,
Furthermore, micro-M existing in various living organisms such as these metabolites
゛Ingredients can be mentioned.

そのような微量成分は主として免疫反応における抗原抗
体反応またはこれに類する反応、例えばホルモンとそれ
に対する抗体または受容体を応用して測定されている。
Such trace components are mainly measured by applying antigen-antibody reactions or similar reactions in immune reactions, such as hormones and antibodies or receptors against them.

抗原抗体反応の結果、それらの結合物が不溶性になった
り、多数の抗原・抗体分子からなる大きな集合体が形成
されることを利用する方法は既に古曲的な方法として知
られてhる。これらは試験管内に沈降する量を直管?1
l11定する方法や、ゲル内で沈降させる免疫拡散法、
あるいは抗原抗体結合物に結合する補体を用いる方法に
より測定されている。また、種々のノ・ブチン1抗原や
抗体を何らかの方法で標識しておき、その標識を測定す
ることによる方法もよく知られている。これらの内でも
高感度測定法として広く用いられている方法にラジオイ
ムノアッセイ但IA)があるが、RIAけ放射性同位元
素を利用するもので、またより安全な測定法として放射
性同位元素標識の代りに酵素で標識したものを用いる測
定法即ち酵素免疫測定法(B I A)が近年広く利用
されている。
Methods that take advantage of the fact that as a result of antigen-antibody reactions, the combination thereof becomes insoluble or a large aggregate consisting of a large number of antigen/antibody molecules are formed are already known as classical methods. Are these straight tubes the amount that settles in the test tube? 1
method for determining l11, immunodiffusion method for precipitation in gel,
Alternatively, it is measured by a method using complement that binds to an antigen-antibody complex. Also, a method is well known in which various Nobutin 1 antigens and antibodies are labeled by some method and the labels are measured. Among these methods, radioimmunoassay (IA) is widely used as a highly sensitive measurement method, but RIA uses radioisotopes and is a safer measurement method in place of radioisotope labels. In recent years, enzyme immunoassay (BIA), a measurement method using enzyme-labeled substances, has been widely used.

EIAは薬物や抗原(fill々の)・ブテンを含む:
以下単に抗原と記す、る)または抗体に酵素を結合させ
゛〔おき、その酵素活性を標識として抗原抗体反応の程
度を測定し、その結果より抗原または抗体の晴を測定し
ようとするものである。
EIA includes drugs and antigens (fills) and butenes:
In this method, an enzyme is bound to an antigen (hereinafter simply referred to as an antigen) or an antibody, the degree of antigen-antibody reaction is measured using the enzyme activity as a label, and the degree of antigen-antibody reaction is measured from the results. .

このような測定法としては、測定しようとするものが抗
原である場合と抗体である場合、標識抗原゛または抗体
と標識しない(非lli識)抗原または抗体を競争的に
反応させる場合と競争させない場合、更に競争反応のと
きに抗原・抗体結合物と非結合物とを分離して測定する
場合と分離しな旨で測定する場合、などがあげられ、さ
らにサンドイツチ法もあげら」Lる。
In such a measurement method, when the substance to be measured is an antigen or an antibody, a labeled antigen or antibody is competitively reacted with an unlabeled (non-labeled) antigen or antibody. In addition, there are cases where antigen-antibody bound substances and non-bound substances are separated and measured during a competitive reaction, and cases where they are measured without separation, and the Sand-Deutsch method is also mentioned.

本発明の免疫測定用同相担体を用いる測定法は、これら
の方法の内で競争反応法やサンドイツチ法に用りられる
測定法であり、その内でも特に不溶性担体である測定用
固相担体を抗体や抗原の1!′l定化(不溶化)のため
に用かた方法である。更に詳しく云えば、本発明の免疫
測定用同相担体を用いる測定法は、スルホン酸基を導入
したポリスチレン固相担体にIgGまたはその第1抗体
または第2抗体を固定化した同相担体を用い北方法であ
る。
The assay method using the in-phase carrier for immunoassay of the present invention is an assay method used in the competitive reaction method or the Sand-Deutsch method among these methods, and in particular, the assay method using the solid phase carrier for measurement, which is an insoluble carrier, is used as an antibody. And antigen 1! This is a method used for constantization (insolubilization). More specifically, the measurement method using the in-phase carrier for immunoassay of the present invention uses an in-phase carrier in which IgG or its first antibody or second antibody is immobilized on a polystyrene solid phase carrier into which sulfonic acid groups have been introduced, and is carried out by the Kita method. It is.

不溶性担体を用いた従来の免疫測定法においては、抗体
固定担体としてナイロン、ポリスチレンやガラス製の球
状担体やペーパーディスク状担体等を用いたものであっ
た力、または反応管壁面を担体としで利用していたが、
これらの不溶性担体に固定される抗原や抗体の鍍は少な
く、満足のかくものではなかった。
In conventional immunoassay methods using insoluble carriers, spherical carriers or paper disk-shaped carriers made of nylon, polystyrene, or glass are used as carriers for immobilizing antibodies. I was doing it, but
The number of antigens and antibodies immobilized on these insoluble carriers was small and unsatisfactory.

本発明者らは、先にこれら種々の欠点を有する免疫測定
用固相担体を改良することを試み、特殊な形状例えば弾
丸状に成型した同相担体(特願昭56−101365号
)を発明したが、固相担体として一般的に使用されるポ
リスチレンの場合、その物理的吸着力が弱く、結合抗体
が剥離し易く、またその吸着−針が少ない等の欠点を有
しているので、必らずl−も実用的とは云えなかった。
The present inventors previously attempted to improve solid phase carriers for immunoassays that have these various drawbacks, and invented a homophase carrier molded in a special shape, for example, a bullet shape (Japanese Patent Application No. 101365/1982). However, polystyrene, which is commonly used as a solid phase carrier, has disadvantages such as weak physical adsorption, easy detachment of bound antibodies, and lack of adsorption needles. Zl- could not be said to be practical either.

本発明は上記のような神々の欠点を改善するために研究
開発されたもので烏って、その目的とするところは、不
溶性担体であるスチレン系ポリマーの測定用担体を発煙
硫酸tたは無水硫酸中にて低県下で処理することにより
得られたスルホン酸基を導入された同相担体が未処理の
ものに比べて7〜l (1倍以上抗原や抗体などの免疫
成分を結合し得る極めて良好なものであることを知り、
さらに好ましくはこの担体を特殊な構造に形成し、該測
定用同相体によって反応管内で接触面積を増大さぜ、さ
らに測定用固相担体に対する反応液の接触面を均一な層
とすることにより、攪拌、振とうなどの煩雑な操作を必
須とせず、また著しく少ない免疫反応媒体の使用にて、
その免疫反応を迅速かつ均一な条件下で行えるようにし
た免疫測定用固相担体紮提供するにある。
The present invention has been researched and developed in order to improve the above-mentioned drawbacks, and its purpose is to convert a styrene-based polymer measurement carrier, which is an insoluble carrier, to fuming sulfuric acid or anhydrous. The in-phase carrier introduced with sulfonic acid groups obtained by treatment in sulfuric acid at a low temperature has an extremely high capacity to bind immune components such as antigens and antibodies by 7 to 1 times more than untreated carriers. Knowing that it is good,
More preferably, this carrier is formed into a special structure, the contact area is increased in the reaction tube by the measurement homomorphic substance, and the contact surface of the reaction liquid with the measurement solid phase carrier is made into a uniform layer. It does not require complicated operations such as stirring or shaking, and uses significantly less immunoreaction medium.
An object of the present invention is to provide a solid phase carrier ligature for immunoassay, which allows the immune reaction to be carried out quickly and under uniform conditions.

本発明は、EIAやRIAにも応用できる。更に本発明
性、同相法などによる競争反応法やサンドイッチ法によ
る測定法に応用できる。
The present invention can also be applied to EIA and RIA. Furthermore, the present invention can be applied to competitive reaction methods such as the in-phase method and measurement methods using the sandwich method.

本発明で使用されるスチレン系ポリマーの不溶性担体と
しては、一般の1fllA −? RIAに用いられる
スチレン系ポリマーの不溶性担体が使用さ)Lる。
As the insoluble carrier for the styrenic polymer used in the present invention, general 1fllA-? An insoluble carrier of styrenic polymer used in RIA is used.

マタ、このスチレン系ポリマーとしては、スチレンから
、するモノポリマーでもよく、マだスチレンとアミノス
チレン、ジビニルベンゼン、アクリルアミド、エチレン
、′メクリル酸、メタアクリル酸、メチルメタアクリレ
ート、アクリニトリルビニルアルコール、酢酸ビニル、
ブタジェン、無水マレイン酸とのコポリマーであっても
よい。このスチレン系ポリマーの不溶性担体としての測
定用111」担体は、球状形として用いてもよく、!侍
に好ましく1よ弾丸状あるいは4a形状その他これに類
する形状のもので、他の固体成型物たとえば金H,プラ
スチックの表面に本発明の測定用同相担体の形状が保持
されるように付着形成させたものでもよ−。
The styrenic polymer may be a monopolymer made from styrene, such as styrene and aminostyrene, divinylbenzene, acrylamide, ethylene, methacrylic acid, methacrylic acid, methyl methacrylate, acrinitrile vinyl alcohol, acetic acid. vinyl,
It may also be a copolymer with butadiene and maleic anhydride. This styrenic polymer as an insoluble carrier for measurement 111'' carrier may be used in spherical form,! It is preferable for Samurai to have a bullet shape, 4A shape, or similar shape, and is formed by adhering it to the surface of another solid molded object such as gold H or plastic so that the shape of the in-phase support for measurement of the present invention is maintained. Even if it's something.

次に本発明の測定用固相担体の好ましい構造例について
図面を参照しながら説明する。
Next, preferred structural examples of the solid support for measurement of the present invention will be explained with reference to the drawings.

第1図は測定用固相担体が符号1として総括的に示しで
ある。測定用固相担体lけ、例えばポリスチレン系の高
分子樹脂材料から成り、担体本体2と該本体2の上面部
2aの中央部忙突出して設けらり、たJll((=J’
 It’ll 3とから構成されている。取付脚3には
、曲の操作棒(図示せず)がはめ込んで取付りられるが
、取イτ1脚3自体を操作棒として使用するために延縄
させ、た形状であってもよい。担体本体2は弾丸状に成
型されてbて、その外径は反応?!r4の内径と僅かな
隙間を保つような径に形成しである。担体本体2の下周
面の頂部には、クサビ状の突起5が一体に設けてあって
、該突起5により、担体本体2の弧状外周面2bと反応
管4との弧状内周面4aとの間に一定の間隙部6が保持
されるようKなっている。また、クサビ状の突起50代
わりに凸状の突起となしてもよ−。要は、突起5により
、担体本体2が反応管4の弧状内周面4aと密着状態と
なることを防止し得る形状であればよい。ξの突起部の
高さとしては、担体本体2と反応管4の管内壁面との1
6(が同一となればよい。担体本体2の上面部2aには
、第2図に示すように1取付脚3を中心部して四角形状
に切り込み溝8が付設しである。切勺込み溝8の終端は
、担体本体2の周縁部に開口させてあって、上面部2a
の殉長線上での反応液の表面張力を弱める様に考慮しで
ある6また、この切り込みm8の形状としては、断面形
状が半円状、楕円状、台形状、三角形状、四角形状など
のhずれの形状であってもよい。
In FIG. 1, the solid phase carrier for measurement is generally indicated by the reference numeral 1. The solid phase carrier for measurement is made of a polystyrene polymer resin material, for example, and is provided with a carrier body 2 and an upper surface 2a of the body 2 protruding from the center.
It'll consist of 3. A music operating rod (not shown) is fitted into the mounting leg 3 and attached, but the handle τ1 leg 3 itself may be shaped like a long rope to be used as an operating rod. The carrier body 2 is molded into a bullet shape, and its outer diameter is reactive. ! It is formed to a diameter that maintains a small gap with the inner diameter of r4. A wedge-shaped projection 5 is integrally provided on the top of the lower peripheral surface of the carrier body 2, and the projection 5 connects the arcuate outer peripheral surface 2b of the carrier main body 2 and the arcuate inner peripheral surface 4a of the reaction tube 4. K so that a constant gap 6 is maintained between the two. Further, instead of the wedge-shaped projection 50, a convex projection may be used. In short, any shape may be used as long as the projections 5 can prevent the carrier main body 2 from coming into close contact with the arcuate inner circumferential surface 4a of the reaction tube 4. The height of the protrusion ξ is 1 between the carrier body 2 and the inner wall surface of the reaction tube 4.
6 (only need to be the same. As shown in FIG. 2, the top surface 2a of the carrier main body 2 is provided with a square cut groove 8 with one mounting leg 3 in the center. The terminal end of the groove 8 is opened at the peripheral edge of the carrier main body 2 and is opened at the upper surface portion 2a.
In order to reduce the surface tension of the reaction solution on the critical line of 6, the shape of this cut m8 may be semicircular, elliptical, trapezoidal, triangular, square, etc. The shape may be shifted by h.

本発明のn++j定用両定損両相担体記の様な構造であ
るため、反応管4に入れた反応液中に担体本体2を浸漬
させれば、担体本体2の突起5が反応管4の内底部に接
触して担体本体2の外周面とそれ釦対応する反応管4の
内周面との間に僅かな隙間が形成される(第1図参照)
。したがって、反応液量が少敬であっても、担体本体2
の浸漬によりて、その液が隙間部に案内されるとともに
担体本体2の上面部にまで上昇され、さらにその反応液
は、切り込みO8内を流れて上面部での表面張力作用を
失う。それ故、反応液は、担体本体2の外周面全体にわ
たって均一な条件(一定厚の屑の形態)で接触すること
Kなる。
Since the structure is similar to that of the n++j constant-loss, double-phase carrier of the present invention, when the carrier body 2 is immersed in the reaction liquid placed in the reaction tube 4, the protrusions 5 of the carrier body 2 are connected to the reaction tube 4. A slight gap is formed between the outer circumferential surface of the carrier body 2 and the inner circumferential surface of the reaction tube 4 corresponding to the button (see Fig. 1).
. Therefore, even if the amount of reaction liquid is small, the carrier body 2
By immersion, the liquid is guided into the gap and raised to the upper surface of the carrier body 2, and the reaction liquid flows through the notch O8 and loses the surface tension effect on the upper surface. Therefore, the reaction liquid contacts the entire outer circumferential surface of the carrier body 2 under uniform conditions (in the form of debris with a constant thickness).

上記の様な切)込み溝8の変形例としては、第3図(イ
)K示すように、担体本体2の上面部2aの半径方向に
放射状に配設してもよい。また、他の変形例としては、
第3図(ロ)に示すように、担体本体2の上面部2aの
直径方向に直線状に配設【〜てもよh0更に他の変形例
としては、第3図(ハ)に示すように、担体本体2の上
面部2aの円周方向に左右対称の形に配設してもよい。
As a modification of the cut grooves 8 as described above, they may be arranged radially in the radial direction of the upper surface portion 2a of the carrier main body 2, as shown in FIG. 3(A)K. Also, as another modification,
As shown in FIG. 3(B), the carrier body 2 is arranged linearly in the diametrical direction of the upper surface 2a of the carrier main body 2. Alternatively, they may be arranged symmetrically in the circumferential direction of the upper surface portion 2a of the carrier body 2.

このように、切り込み/i¥ 8は、その終端が上面部
2aの周縁部に開11されている形状であればよく、ま
た如何なる形状にイ1設することもできる。
In this way, the cut /i\8 may have any shape as long as its terminal end is open 11 at the peripheral edge of the upper surface portion 2a, and it can be formed in any shape.

第4図は測定用固相担体lの他の変形例を示したもので
ある。この構造例における担体本体2は槍形状に形成し
である。したがって、反応管4も担体本体2に沿うテー
パー形状のものが使用される。従って、これから理解さ
れるように、種々の市販の反応管の形状に従って、その
担体本体を変形、加工すればよい。なお、第4図の実施
例における担体本体2のその他の構造については、前記
第1図で示した実施例のものと同じであるため、それと
構造を同じくする部分には同じ齢号を付し、説明は省略
する。
FIG. 4 shows another modification of the solid phase support 1 for measurement. The carrier body 2 in this structural example is formed into a spear shape. Therefore, the reaction tube 4 is also tapered along the carrier body 2. Therefore, as will be understood from this, the carrier body may be modified and processed according to the shape of various commercially available reaction tubes. The other structure of the carrier body 2 in the embodiment shown in FIG. 4 is the same as that in the embodiment shown in FIG. , the explanation is omitted.

上記の如き、固相担体は種々の形状に形成されるが、例
えば弾丸状の固相担体の裏作のための実測例を第5図に
りbて説明する。
As mentioned above, the solid phase carrier can be formed into various shapes, and an actual measurement example for forming the backing of a bullet-shaped solid phase carrier, for example, will be explained with reference to FIG.

例えば使用される小試験管が15X1(15ynWL(
内径12.8m、m±n、 1my+L)の場合、担体
本体2は第5図に符号人ないし工で示す各部寸法KIA
作される。すなわち、A:半径6mmの半球部、B:円
柱部の高さ10mm、 、C:円錐状突起部の高さく)
、4m’WL % D :円錐状突起部の円錐の半径0
.5tntn % E :半径0.75mmの半円状溝
、F:対向する溝間の中心部距離7.5mm 、 G 
:操作棒を挿着するための凸部の直径4 m、m%H:
操作棒挿着孔の直径2mmsI:挿操神挿着のための凸
部の高さ3 mmの寸法に−〔示される円柱部、(高さ
l Omm s直径12mm1と半径6mmの半球部か
らなる担体本体で、免投結衝液の計け1(] 0 /i
β程度、標識物質を結合させた成分を金山する液は10
0/l、e稈度および被検液(血清、尿等)は1()θ
μm程度を用いればよい。
For example, the small test tube used is 15X1 (15ynWL)
In the case of an inner diameter of 12.8 m, m±n, 1 my+L), the carrier main body 2 has the dimensions of each part KIA indicated by the reference numeral or number in Fig. 5.
made. That is, A: hemispherical portion with a radius of 6 mm, B: height of the cylindrical portion: 10 mm, C: height of the conical protrusion)
, 4m'WL % D: Radius of cone of conical protrusion 0
.. 5tntn% E: Semicircular groove with a radius of 0.75 mm, F: Center distance between opposing grooves 7.5 mm, G
: Diameter of the convex part for inserting the operating rod 4 m, m%H:
The diameter of the operation rod insertion hole is 2 mm.I: The height of the protrusion for insertion of the insertion rod is 3 mm. Measure the buffer solution on the carrier body 1(] 0 /i
About β, the liquid that binds the labeled substance is 10
0/l, e culm degree and test liquid (serum, urine, etc.) are 1()θ
A value on the order of μm may be used.

また、この際反応液の液層の幅(厚み)は(1,4mM
Lと均一に形成されるものである。
In addition, at this time, the width (thickness) of the liquid layer of the reaction solution was (1.4 mm
It is formed uniformly with L.

」二記の1清造例のように形成された担体本体を、発煙
硫酸または無水硫酸液中に加え、通常冷却下、例えば5
℃程度にて2時間以上浸漬せしめて反応せしめスルフォ
ン酸基を導入する。
The carrier body formed as in Example 2-1 is added to fuming sulfuric acid or anhydrous sulfuric acid solution, usually under cooling, for example,
The sample is immersed for 2 hours or more at a temperature of about 0.degree. C. to react and introduce sulfonic acid groups.

このようにして得られたスルフォン酸基t 18人した
測定用担体に1m常公知の手段を適用して化学的または
物理的に抗体もしくは抗原、その他の薬物の受容体を結
合して不溶性抗体等(抗原、受容トド)となし、同相を
潤整する。
The sulfonic acid group obtained in this manner is chemically or physically bound to the receptor for antibodies, antigens, and other drugs by applying conventional means to the carrier for measurement to form insoluble antibodies. (antigen, receptor) and hydrates the same phase.

同相の調製法としCは、前8C不I4注担体にあらかじ
め抗体等を結合せしめるための官能基を導入してIl’
¥定の形状に加工してもよく、または加工した後に官能
基を導入してもよい。この同相を得るにあたっては、硫
酸処理されたスチレン系ポリマーと免疫成分とを水性媒
体中にて接触せしめることにより、その大部分がイオン
結合によって固定化されるものである。さらに、一般忙
化学的に固定化するKあたりては、スチレン系ボリマー
ノ不溶性担体の分子内の官能基または導入された官能基
と、抗体等の分子内に有する官能基、例えばアミン基、
水酸基、カルボキシル基、チオール基、アルデヒド基等
の官能基に基いで両者を結合し得る多官能性化合物が用
すられる。この公知のg々の多官能性化合物としCは、
例えはへギザメチレンジイソシアナート、2.4−)ル
エンジイソンアナートなどのジイソシアナート化合物、
ヘキザメチレンジイソチオシ゛アナートなどのジイソヂ
オシアナート、スクシンアルデヒド、グルタルアルデヒ
ド、アジボアルデヒドなどのジアルデヒド、N1N−エ
チレンビスマレイミド、N、N’−0−フェニレンジマ
レイミド、ビビスジアゾベンジジン、N。
In the in-phase preparation method, C is prepared by introducing a functional group for binding an antibody, etc. to the pre-8C-I4 injection carrier in advance.
It may be processed into a specific shape, or a functional group may be introduced after processing. To obtain this same phase, the styrene-based polymer treated with sulfuric acid and the immune component are brought into contact with each other in an aqueous medium, and most of the components are immobilized by ionic bonds. Furthermore, for K to be immobilized in a general chemical manner, a functional group in the molecule of the styrene-based polymano-insoluble carrier or a functional group introduced therein, a functional group in the molecule of the antibody, etc., such as an amine group,
A polyfunctional compound capable of bonding the two based on a functional group such as a hydroxyl group, a carboxyl group, a thiol group, or an aldehyde group is used. This known polyfunctional compound C is
Diisocyanate compounds such as hegizamethylene diisocyanate, 2.4-)luene diisonanate,
Diisodiocyanates such as hexamethylene diisothiocyanate, dialdehydes such as succinic aldehyde, glutaraldehyde, and azibaldehyde, N1N-ethylene bismaleimide, N,N'-0-phenylene dimaleimide, bis Diazobenzidine, N.

N1−ポリメチレンビスヨードアセトアミド、ジエチル
マロンイミデー)・、ジメチルアジピンイミデート、3
−(2−ベンゾチアゾリル−ジチオ)−プロピオン酸、
3−(2−ピリジル−N−オキサイド−ジチオ)プロピ
オン酸、6−N[3−(2’−ベンゾチアゾリル−ジチ
オ)グロビオニル〕カプロン酸などのスルフィドカルボ
ン酸類またはそのスクシンイミドエステル、P−ニトロ
フェニルエステル、酸クロライド、イミデートなどの反
応\伸性導体(特願昭53−85900号参照)、マし
イミド安息香酸、マレイミドフェニル酢酸、マレイミド
フェニルプロピオン酸などのマレイミドカルボン酸類ま
たはその反応性誘導体などが挙らノLる。
N1-Polymethylenebiiodoacetamide, diethylmalonimidate), dimethyladipineimidate, 3
-(2-benzothiazolyl-dithio)-propionic acid,
Sulfide carboxylic acids such as 3-(2-pyridyl-N-oxide-dithio)propionic acid, 6-N[3-(2'-benzothiazolyl-dithio)globionyl]caproic acid, or their succinimide esters, P-nitrophenyl esters, Reactions of acid chlorides, imidates, etc.\stretchable conductors (see Japanese Patent Application No. 53-85900), maleimidocarboxylic acids such as maleimidobenzoic acid, maleimidophenyl acetic acid, maleimidophenylpropionic acid, and their reactive derivatives.ノLru.

またこの多官能性化合物は、不溶性担体に官能Jぶを導
入するための官能基導入試薬としても使用、できるもの
である。
This polyfunctional compound can also be used as a functional group introduction reagent for introducing a functional group into an insoluble carrier.

さらKまた、免疫成分を固定化し念同相を得るKあたっ
ては、例えばpH6〜8の緩衝液やアセトン、メタノー
ル、エタノールナトのアルコール系媒体、ジエチルエー
テルなどのエーテル系媒体゛またはそれらの混合媒体な
どの不活性媒体中にて、冷却または室温にて、不溶性担
体と多官能性化合物を反応せしめる。その後必要に応じ
て洗浄し、さらに同様の不活性媒体中にこれを加え、さ
らに抗体等を加え反応せしめて不溶け4す体と抗体等を
反応せしめる。
In addition, to immobilize the immune components and obtain the same phase, for example, a buffer with a pH of 6 to 8, an alcoholic medium such as acetone, methanol, or ethanol, an etheric medium such as diethyl ether, or a mixed medium thereof can be used. The insoluble carrier and the polyfunctional compound are allowed to react in an inert medium such as, at cooling or room temperature. Thereafter, it is washed as necessary, and further added to the same inert medium, and then an antibody or the like is further added and reacted to cause the insoluble body to react with the antibody or the like.

以下、同相担体の調?!法と同相担体における抗体の吸
着の例とし°CIgGの吸着例を詳しく説明する。
Below is the key of the in-phase carrier? ! As an example of the adsorption of an antibody on a support in the same phase as the method, an example of adsorption of CIgG will be explained in detail.

所定の形状に成型したポリスチレン製同相相体を5℃に
て1時間前処理した後、冷却した濃硫酸中に入れ5℃で
・1〜16時間、aIましくii:f’i時間反応せし
める。反応後、同相担体を取り出し蒸留水にて充分に洗
滌し、更に1 tl OmM リン酸緩衝液(pH8,
n)で充分に洗滌をくり返してスルフォン酸基を導入し
たポリスチン固、10」1体を得る。
A polystyrene homophase body molded into a predetermined shape was pretreated at 5°C for 1 hour, then placed in cooled concentrated sulfuric acid and allowed to react at 5°C for 1 to 16 hours, aI or ii:f'i. . After the reaction, the in-phase support was taken out and thoroughly washed with distilled water, and then added with 1 tl OmM phosphate buffer (pH 8,
Washing is repeated sufficiently in step (n) to obtain one polystin solid 10'' into which sulfonic acid groups have been introduced.

この同相担体を、その直径より僅かに大きな直径を有す
る試験管にあらかじめIgG溶液を少鮒入れたものに挿
入して、5℃にて適当時間例えば2−16時間インキュ
ベートすることにより、同相担体にIgGを吸着せしめ
ることができる。
This in-phase carrier is inserted into a test tube having a diameter slightly larger than the diameter of the in-phase carrier, which has previously been filled with a small amount of IgG solution, and incubated at 5°C for an appropriate period of time, e.g., 2-16 hours. IgG can be adsorbed.

いま、内径12.8mm±0.Lmmの試験管に、直径
12.0mmの第5図に示される弾丸状に成型したスル
フォン酸基を導入した固相担体を使用し九場合のIgG
の吸着について述べること圧する。
Currently, the inner diameter is 12.8mm±0. A solid phase carrier with sulfonic acid groups introduced into a bullet shape with a diameter of 12.0 mm as shown in Fig. 5 was used in a test tube of 9 mm in diameter.
Talk about the adsorption of pressure.

上記試験管にウサギIgGの1 (10mMリン酸緩衝
液(pH8,0)溶液o 、 4m0 (I gG i
tとして25ttg/me 。
In the above test tube, add rabbit IgG (10mM phosphate buffer (pH 8,0) solution o, 4m0 (IgGi
25ttg/me as t.

50μg/meおよび100μg/meを各々別々の試
験管に入れる)を加え、上記スルフォン酸基を導入した
ポリスチレン製固相担体を挿入し、適当時間(0,2,
4,6,8,16時間)5℃にてインキュベートする。
Add 50 μg/me and 100 μg/me into separate test tubes, insert the polystyrene solid phase carrier into which the sulfonic acid group has been introduced, and incubate for an appropriate time (0, 2,
Incubate at 5°C for 4, 6, 8, 16 hours).

反応後、固相担体を引出し、100mMリン酸緩衝液(
pH8,0)にて洗滌し、残った試験管内のIgG溶液
の蛋白J(をCu−Folin法にて測定し、吸* I
gG景をしらべる。結果は第6図に示すごとく、無処理
のポリスチレン固相担体を用い九場合に比べ10μgA
llr相担体の場合で約7.5倍、20μgおよび40
tig/固相担体の場合で約10倍IgGの固定化if
tが上昇した。この事実から、本発明の固相担体が抗体
の結合液が無処理に比べきわめて大であり、少量の担体
で充分反応性に當む抗体結合抗体であることが判る。
After the reaction, pull out the solid phase carrier and add 100mM phosphate buffer (
The protein J of the remaining IgG solution in the test tube was measured by the Cu-Folin method, and the absorption *I
Check out the GG scenery. As shown in Figure 6, the results showed that 10μgA was obtained using an untreated polystyrene solid support.
Approximately 7.5 times for llr phase support, 20 μg and 40
About 10 times more IgG immobilization if using tig/solid phase carrier
t has increased. From this fact, it can be seen that the solid phase carrier of the present invention has a much larger antibody-bound solution than the untreated carrier, and that a small amount of carrier is sufficient for the antibody-bound antibody to have sufficient reactivity.

また、工gGと同相Ju体の結合の安定性についてしら
べた結果を以下に述べる。
In addition, the results of an investigation on the stability of the bond between gG and the homologous Ju form are described below.

IgGを固定化した同相担体を下記の2通りの処理をす
ることにより、結合安定性をしらべた。イオン結合によ
る固定化物の解離法として、IN塩酸室温3時間処理、
物理的吸着による固定化物のjQTfll法として10
%SDS室温30分間処理を行ない、遊離してくるIg
Gを測定することによ、D、IgGの結合線式をしらべ
た。
The binding stability was examined by subjecting the in-phase carrier on which IgG was immobilized to the following two treatments. As a method for dissociating immobilized substances by ionic bonding, treatment with IN hydrochloric acid at room temperature for 3 hours,
10 as the jQTfl method for immobilized substances by physical adsorption.
%SDS at room temperature for 30 minutes, the released Ig
By measuring G, the bonding equation of D and IgG was investigated.

上記の表に示した通り、硫酸処理したポリスチレン製周
相担体においては、固定化されたIgGの約85−のも
のが、イオン的にきわめて安定した形で同相と結合する
ことが明らかであシ、本発明の固相担体はきわめて結合
安定性のよい担体であることが判る。
As shown in the table above, it is clear that in the polystyrene peripheral phase carrier treated with sulfuric acid, about 85- of the immobilized IgG binds to the same phase in an extremely stable ionic form. It can be seen that the solid phase carrier of the present invention has extremely good binding stability.

次に、本発明の同相担体における抗体の活性保持率を仙
の担体と比較した例を述べる。
Next, an example will be described in which the activity retention rate of an antibody in the same-phase carrier of the present invention is compared with that of the same carrier.

3鍾の固相担体に抗モルモットIgに (ウツギ)のI
gG画分20μgの100フルMリン酸緩衝液(pif
 8.0)溶液(抗体含有11約2チ)を室温で3時間
、5℃で1晩反応させた後、残存のIgG−Ifを測定
することにより、吸着IgG letを求めた。次に、
モルモットIgU Ipqを抗体1i’11定化固相担
体に5℃で1晩作用さす、免疫反応により同相に結合し
たモルモットIgG hJを求めた。そこで、抗体の活
性保持率上記の表に示した通り、ポリスチレン製固相担
体は、無処理同相担体とほぼ同4″A度の活性保持率を
示し、ナイロン郷固相担体に比べ、はるかに良好な保持
率であった。
Anti-guinea pig Ig (Deutsche spp.) I on a 3-piece solid phase carrier
20 μg of gG fraction in 100 full M phosphate buffer (pif
8.0) The adsorbed IgG let was determined by measuring the remaining IgG-If after reacting the solution (approximately 2 ml of antibody-containing 11) at room temperature for 3 hours and at 5° C. overnight. next,
Guinea pig IgG hJ bound to the same phase was determined by an immunoreaction in which guinea pig IgU Ipq was applied to the antibody 1i'11 fixed solid phase carrier overnight at 5°C. Therefore, as shown in the table above, the polystyrene solid phase support exhibits an activity retention rate of 4''A degree, which is almost the same as the untreated same phase support, and is far superior to the nylon solid phase support. The retention rate was good.

なお、上記のナイロン製同相用体についてはイミクロ法
によりアミノ基を導入した後、グルタルアルデヒド法で
活性化したものを用いた。
In addition, the above-mentioned nylon homogeneous body was used after introducing an amino group by the immicro method and then activating it by the glutaraldehyde method.

以上述べた如く、本発明のスルフォン酸基導入ポリスチ
レン製固相担体は、担体当りの抗体の固定化箪がきわめ
て大であり、従って抗体を匝小4(使用することによ巾
、充分免疫測定が可能であるばかりでなく、結合した抗
体もきわめて安定な形で存在するので、長時間、頻回の
1史用に耐える上、抗体の活性保持率も良好である等、
きわめてすぐり、た免投測足用担体である。
As mentioned above, the sulfonic acid group-introduced polystyrene solid phase carrier of the present invention has an extremely large capacity for immobilizing antibodies per carrier, and therefore, it is possible to immobilize antibodies with a width of 4 sq. Not only is this possible, but the bound antibody also exists in an extremely stable form, so it can withstand repeated use over a long period of time, and the activity retention rate of the antibody is also good.
This is an extremely good carrier for the foot test.

本発明の同相担体において、it(2抗体を用いて第1
抗体を結合せしめてなる担体表面−第2抗体−第1抗体
結合物を得るにあたっては、向えば1旧の形状に加工し
た測定用担体t・m−で、上述の如くの同相を肖る手段
に基いて、まずg32抗体を結合せしめる。次いでこれ
に、第1抗体を加えて免疫反応に糸いて結合せしめれば
よく、このようにして得られた第1抗体の免疫活性tよ
ケ1とんど劣化されないために管に好ましい同相である
In the in-phase carrier of the present invention, the first
In order to obtain a carrier surface-second antibody-first antibody conjugate formed by binding an antibody, it is necessary to use a measurement carrier t/m- which has been processed into a conventional shape, and to obtain the same phase as described above. Based on this, g32 antibody is first bound. Next, the first antibody is added to this and allowed to bind through the immune reaction, and the immune activity of the first antibody obtained in this way is in the same phase, which is preferable for the tube because it hardly deteriorates. be.

さらに、測定にあ之って用いられる酵素を結合させた成
分、例えば抗体、抗原、21ブテンなどや敏剖性同fS
″L元素を結合させた成分は、公知のEIAt−RIA
に用いられる標#メ丸めの手段が用いられる。また、標
識物質としての酵素としては、公知のlii々の酵素、
例えば酸化還元酵素、加水分解酵素、転1j″L酵素、
リアーゼ、イソメラーゼ、リガーゼに墾4する酵素力!
利用できる。
In addition, enzyme-conjugated components used in the measurement, such as antibodies, antigens, 21-butene, etc.
``The component to which the L element is bonded is the well-known EIAt-RIA.
The standard rounding method used in In addition, as enzymes as labeling substances, known enzymes,
For example, oxidoreductase, hydrolase, trans1j″L enzyme,
Enzyme power that develops into lyase, isomerase, and ligase!
Available.

この様にして測定用担体に固定した不溶化抗体り「「を
用いて、この抗体等に対して特異的結合性を[)′J−
るalll定ずべき成分、例えば抗原、抗体を測定I−
るためには、公知のglAまたけRIAによる測定法が
適用される。
Using the insolubilized antibody immobilized on the measurement carrier in this way, the specific binding property for this antibody etc. is determined by [)'J-
Measure all components to be determined, such as antigens and antibodies.
For this purpose, a known measurement method using glA spanning RIA is applied.

以下、実施例をあげて本発明を具体的に説明するが、本
sb明はこれにのみ限定されるものではない。
EXAMPLES Hereinafter, the present invention will be specifically explained with reference to Examples, but the present invention is not limited thereto.

固相担体の調製法: 第5図に示す如く弾丸状に成型されたポリスチレン製担
体(直径12 、 OtrLm)を5℃にて1時間冷却
前処理を行った。次いで冷却した濃硫酸中に上記の相体
を加え、5℃にて6時間反応させた。反応後、担体を取
り出し、蒸留水にて充分に洗滌した後、100mMリン
酸緩衝液(pHLO)にて充分に洗滌し、スルフォン酸
基を導入したポリスチレン製固相担体をイひた。
Preparation method of solid phase carrier: As shown in FIG. 5, a polystyrene carrier molded into a bullet shape (diameter 12, OtrLm) was pre-cooled at 5° C. for 1 hour. Next, the above phase was added to cooled concentrated sulfuric acid and reacted at 5° C. for 6 hours. After the reaction, the carrier was taken out, thoroughly washed with distilled water, and then thoroughly washed with 100 mM phosphate buffer (pHLO), and the polystyrene solid phase carrier into which sulfonic acid groups had been introduced was immersed.

実施例2 抗体吸着同相担体の調製法: 試験管(内径12.8mm±0.1mm)にウサギIg
Gの1()0mMリン酸緩衝液(pH8,1))溶液(
IgG Jtは夫* 25.50.100μg/ag)
を0.4m、eずつ入れ、これに実施例1で得たスルフ
ォン「硬基を導入したポリスチレン製固相担体を挿入し
、5℃にて、0.2.4.6.8ならびに16時間反応
させた。夫々の時間において、固相担体を取り出し、試
験管内の残存IgG溶液の蛋白類、を銅−フォーリン法
(Cu−Fo l i n法)にて測定して非吸着Ig
GJJNを算出し、固相担体に吸着したIgG量を求め
た。
Example 2 Preparation method of antibody adsorption in-phase carrier: Rabbit Ig was placed in a test tube (inner diameter 12.8 mm ± 0.1 mm).
1 ()0mM phosphate buffer (pH 8,1)) solution of G (
IgG Jt is husband * 25.50.100μg/ag)
0.4 m and e each, and the sulfone obtained in Example 1 was inserted into the polystyrene solid phase carrier into which a hard group was introduced, and the mixture was heated at 5°C for 0.2, 4, 6.8 and 16 hours. At each time, the solid phase carrier was removed, and the proteins in the remaining IgG solution in the test tube were measured using the Cu-Folin method to determine the non-adsorbed Ig.
GJJN was calculated to determine the amount of IgG adsorbed on the solid phase carrier.

結果は、第6図に示すとおりで、ボリスチt/ンそのも
の(無処理ポリスチレン)に比べて、IgG固定化喰は
約7.5−10倍上昇していることが判った。また、反
応時間は2時間で最大吸着績゛に達し、後は平衝状態に
なる仁とも判った。
The results are shown in FIG. 6, and it was found that the IgG immobilization rate was about 7.5 to 10 times higher than that of Boristine itself (untreated polystyrene). It was also found that the reaction time reached the maximum adsorption capacity in 2 hours, and then reached an equilibrium state.

【図面の簡単な説明】[Brief explanation of drawings]

図面は本発明の好適な実施例を示j−ものであって、第
1図は第1夾施例による免疫測定用固相担体を試験管に
挿入した状態の部分断面図、第2図は免疫測定用固相、
担体の平面図、第3図ビ)(ロ)(ハ)は、担体釦形成
さ・れる切込み溝の夫り異なる実施例を示す平面図、第
4図は第2実施例の免疫測定用固相担体の縦断面図、第
5図は免疫測定用同相担体jlt″!作のための1例の
実測図、第6図は1^1相担体に吸着するIgGJlの
グラフ図である。 符号の説明 ■は免役測定用担体、2は担体本体、4は試験管である
。 9 、ρ 第3図 (イ) (ロ) (ハ) 反先・端間  015°C 処工t IgG −O−0−10μ9/匿口旧4旦イ木 −0−0−20pg/固木nキ旦休 (50,Ltg IgG 7m)’?0.4m1)−ム
ーー6−40.Ll(1/固ホBオ旦体(100PcJ
  IgG /m〕6)0.4m17)382
The drawings show preferred embodiments of the present invention, and FIG. 1 is a partial sectional view of the solid phase carrier for immunoassay according to the first embodiment inserted into a test tube, and FIG. Solid phase for immunoassay,
A plan view of the carrier, FIG. 3B)(B), and FIG. A vertical cross-sectional view of the phase carrier, FIG. 5 is an actual measurement diagram of an example for making an in-phase carrier for immunoassay, and FIG. 6 is a graph of IgGJl adsorbed to the 1^1 phase carrier. Explanation ■ is the carrier for immunoassay, 2 is the carrier body, and 4 is the test tube. 9, ρ Figure 3 (a) (b) (c) Between the opposite tip and end 015°C Processing t IgG -O- 0-10μ9/Anonymous old 4th day tree - 0-0-20pg/Koki nki Dankyu (50, Ltg IgG 7m)'?0.4m1)-Moo 6-40.Ll (1/Koho B Odan body (100PcJ
IgG/m〕6)0.4m17)382

Claims (1)

【特許請求の範囲】 (1)スルフォン酸基を導入したスチレン系ポリマーよ
)なる免疫測定用固相担体。 (2;  スチレン系ポリマーがポリスチレンまたはス
チレンからなるモノポリマー、スチレンとアミノスチレ
ン、ジビニルベンゼン、アクリルアミド、エチレン、ア
クリル酸、メタアクリル酸、メチルメタアクリレート、
アクリニトリルビニルアルコール、酢酸ビニル、フタジ
エン、無水マレイン酸との、コポリマーである特許請求
の範囲第1項記載の免疫測定用固相担体。 (3)反応管と一定の隙間部を保っ担体がほぼ弾丸状あ
るいは槍形状その他これに類する形状に成形され、しか
もスルフォン酸基を導入したスチレン系ポリマーからな
る特許請求の範囲第1項に記載の免疫測定用固相担体。
[Scope of Claims] (1) A solid phase carrier for immunoassay consisting of (1) a styrene-based polymer into which a sulfonic acid group has been introduced. (2; Styrenic polymer is polystyrene or a monopolymer consisting of styrene, styrene and aminostyrene, divinylbenzene, acrylamide, ethylene, acrylic acid, methacrylic acid, methyl methacrylate,
The solid phase carrier for immunoassay according to claim 1, which is a copolymer of acrinitrile vinyl alcohol, vinyl acetate, phtadiene, and maleic anhydride. (3) According to claim 1, the carrier is formed into a substantially bullet-shaped, spear-shaped, or similar shape while maintaining a certain gap with the reaction tube, and is made of a styrene polymer having sulfonic acid groups introduced therein. solid phase carrier for immunoassay.
JP19469782A 1982-11-08 1982-11-08 Solid-phase carrier for immune measurement Pending JPS5984161A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP19469782A JPS5984161A (en) 1982-11-08 1982-11-08 Solid-phase carrier for immune measurement

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19469782A JPS5984161A (en) 1982-11-08 1982-11-08 Solid-phase carrier for immune measurement

Publications (1)

Publication Number Publication Date
JPS5984161A true JPS5984161A (en) 1984-05-15

Family

ID=16328763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19469782A Pending JPS5984161A (en) 1982-11-08 1982-11-08 Solid-phase carrier for immune measurement

Country Status (1)

Country Link
JP (1) JPS5984161A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0618185U (en) * 1992-08-18 1994-03-08 オージーケー技研株式会社 Carrying handle for bicycle

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0618185U (en) * 1992-08-18 1994-03-08 オージーケー技研株式会社 Carrying handle for bicycle

Similar Documents

Publication Publication Date Title
US5061640A (en) Process for preparing a carrier useful in immunoassays by deposition of a complex of a specifically binding substance with hydrophobic protein, and the resulting carrier
JP3340434B2 (en) Water-soluble polymer-based reagents and conjugates comprising components derived from divinyl sulfone
US5898005A (en) Rapid detection of analytes with receptors immobilized on soluble submicron particles
US4495151A (en) Element for immunoassay
JPH0235944B2 (en) TOKUITEKIKETSUGOKENTEIOJITSUSHISURUHOHOOYOBIGAIHOHOOJITSUSHISURUTAMENOSHIKENKITSUTO
JPH0814579B2 (en) Measuring method and reagent for specific binding substance
Yoshioka et al. Immobilization of ultra-thin layer of monoclonal antibody on glass surface
US5314830A (en) Immobilized hydrophobically-modified antibodies
US4649105A (en) Method of measuring biological ligand
JPH08503066A (en) Method of chemical bonding to solid phase
EP0336647B1 (en) Determination of arachidonic acid derivatives and kits therefore
JPH01209370A (en) Method and apparatus for measuring immunologically active substance
US5437981A (en) Method for the immunological determination of ligands
EP0166583A2 (en) Compositions for enzyme immunoassay of prostaglandins
JPH0224559A (en) Measurement of immunologically detectable substance, reactor and measurement of various parameters by method by immunoassay theory
JPS5984161A (en) Solid-phase carrier for immune measurement
Boitieux et al. A computerised enzyme immunosensor: application for the determination of antigens
JP2672151B2 (en) Enzyme immunoassay using magnetic substance
HU182464B (en) Process for the determination of the trioxine bond index in serum
KR100298130B1 (en) an apparatus for analyzing cholesterol of plasma lipoprotein and its method
JPS6318704B2 (en)
EP0206779A1 (en) Detecting antinuclear antibody
JP2657672B2 (en) Ultrasensitive specific antibody assay
JPH0510952A (en) Preparation of carrier containing immobilized substance
KR910008704B1 (en) Process for the determination of an immunologically dectection substance and a suitable reaction vessel therefor